Larvol Delta - Secukinumab-in-patients-with-polymyalgia-rheumatica-Subgroup-analyses-of-Week-52-results-of-a-Phase-3-multicentre-randomised-doubleblind-placebocontrolled-trial-REPLENISH

Cosentyx (secukinumab) - Novartis

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1898023&mode=presInfo

Frank Buttgereit, MD (he/him/his)

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next